Mr Eric Steven Seyferth, MD | |
140 Hospital Dr, Suite 310, Bennington, VT 05201-5018 | |
(802) 442-7855 | |
(802) 442-6638 |
Full Name | Mr Eric Steven Seyferth |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 41 Years |
Location | 140 Hospital Dr, Bennington, Vermont |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205836863 | NPI | - | NPPES |
0009437 | Medicaid | VT | |
030320620 | Other | CIGNA | |
11012 | Other | MVP | |
1601 | Other | VT | BCBS VERMONT |
010028337 | Other | RAILROAD MEDICARE | |
T001346 | Other | TRICARE | |
11012 | Other | VT | MVP |
76573 | Other | NY | GHI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 042-0007982 (Vermont) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Vna & Hospice Of The Southwest Region Inc | Rutland, VT | Home health agency |
Southwestern Vermont Medical Center | Bennington, VT | Hospital |
Glens Falls Hospital | Glens falls, NY | Hospital |
Entity Name | Southwestern Vermont Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205865789 PECOS PAC ID: 0143138446 Enrollment ID: O20060929000045 |
News Archive
Reverse Medical Corporation today announced FDA IDE approval for clinical investigation of their BARREL Vascular Reconstruction Device (VRD). The BARREL Vascular Reconstruction Device is designed for use with occlusive devices in the treatment of intracranial bifurcation aneurysms.
Results from the Lipid-Rich Plaque study demonstrate the correlation between the presence of non-flow-limiting, non-intervened upon, lipid-rich plaques detected by NIRS-IVUS imaging and the development of a major adverse cardiac event from a de novo culprit lesion at both the patient level (vulnerable patients) and segment level (vulnerable plaques) within 24 months post intravascular imaging.
Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging technology to identify cancer biomarkers in exhaled air.
A new, innovative form of radiation based on verified scientific facts will be available to patients all over Europe within the next few decades. The official kick-off meeting of the Community project ULICE (Union of LIght Ions Centres in Europe), which the European Union is supporting with nearly 10 million euros, was held in fall 2009 in the Department of Radiooncology and Radiation Therapy of the Heidelberg University Hospital.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Eric Steven Seyferth, MD 140 Hospital Dr, Suite 310, Bennington, VT 05201-5018 Ph: (802) 442-7855 | Mr Eric Steven Seyferth, MD 140 Hospital Dr, Suite 310, Bennington, VT 05201-5018 Ph: (802) 442-7855 |
News Archive
Reverse Medical Corporation today announced FDA IDE approval for clinical investigation of their BARREL Vascular Reconstruction Device (VRD). The BARREL Vascular Reconstruction Device is designed for use with occlusive devices in the treatment of intracranial bifurcation aneurysms.
Results from the Lipid-Rich Plaque study demonstrate the correlation between the presence of non-flow-limiting, non-intervened upon, lipid-rich plaques detected by NIRS-IVUS imaging and the development of a major adverse cardiac event from a de novo culprit lesion at both the patient level (vulnerable patients) and segment level (vulnerable plaques) within 24 months post intravascular imaging.
Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging technology to identify cancer biomarkers in exhaled air.
A new, innovative form of radiation based on verified scientific facts will be available to patients all over Europe within the next few decades. The official kick-off meeting of the Community project ULICE (Union of LIght Ions Centres in Europe), which the European Union is supporting with nearly 10 million euros, was held in fall 2009 in the Department of Radiooncology and Radiation Therapy of the Heidelberg University Hospital.
› Verified 8 days ago
Khola Qamar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 Hospital Dr Ste 307, Bennington, VT 05201 Phone: 802-447-4555 Fax: 802-447-0996 | |
Dr. Patrick J Tangney, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 Hospital Dr Ste 307, Bennington, VT 05201 Phone: 802-447-4555 Fax: 802-440-6087 | |
Dr. David M Gorson, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 140 Hospital Dr, Suite 301, Bennington, VT 05201 Phone: 802-442-3022 Fax: 802-442-4874 | |
Ms. Ashley N Maranino, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 Hospital Dr, Suite 104, Bennington, VT 05201 Phone: 802-447-1536 | |
Scott W Rogge, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 Hospital Drive, Suite 312, Bennington, VT 05201 Phone: 802-442-0800 Fax: 802-442-0212 | |
David M Sischy, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 140 Hospital Dr, Bennington, VT 05201 Phone: 802-447-8650 Fax: 802-447-8653 |